Patients’ Difficulties with Five Different Fecal Immunochemical Tests

References

1. 1.↵
   1. Young GP,
   2. Symonds EL,
   3. Allison JE,
   4. et al

   . Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci 2015;60:609–22.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Knudsen AB,
   2. Rutter CM,
   3. Peterse EFP,
   4. et al

   . U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Colorectal Cancer Screening: An Updated Decision Analysis for the US Preventive Services Task Force. Agency for Healthcare Research and Quality (US); 2021.
3. 3.↵
   1. Davidson KW,
   2. Barry MJ,
   3. Mangione CM

   , US Preventive Services Task Forceet al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2021;325:1965–77.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Zhong GC,
   2. Sun WP,
   3. Wan L,
   4. Hu JJ,
   5. Hao FB

   . Efficacy and cost-effectiveness of fecal immunochemical test versus colonoscopy in colorectal cancer screening: a systematic review and meta-analysis. Gastrointest Endosc 2020;91:684–97.e15.

   OpenUrlPubMed
5. 5.↵
   1. Levy BT,
   2. Daly JM,
   3. Xu Y,
   4. et al

   . Comparative effectiveness of five fecal immunochemical tests using colonoscopy as the gold standard: study protocol. Contemp Clin Trials 2021;106:106430.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Lee JK,
   2. Liles EG,
   3. Bent S,
   4. Levin TR,
   5. Corley DA

   . Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 2014;160:171.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Greenwald B

   . A pilot study evaluating two alternate methods of stool collection for the fecal occult blood test. Medsurg Nurs 2006;15:89–94.

   OpenUrlPubMed
8. 8.↵
   1. Pham R,
   2. Cross S,
   3. Fernandez B,
   4. et al

   . “Finding the right FIT”: rural patient preferences for fecal immunochemical test (FIT) characteristics. J Am Board Fam Med 2017;30:632–44.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Daly JM,
   2. Xu Y,
   3. Levy BT

   . Which fecal immunochemical test should I choose? J Prim Care Community Health 2017;8:264–77.

   OpenUrlPubMed
10. 10.↵
    1. Daly JM,
    2. Xu Y,
    3. Crockett SD,
    4. Schmidt ME,
    5. Kim P,
    6. Levy BT

    . Clock-drawing test as a screening tool for cognitive impairment associated with fecal immunochemical test collection errors. Ann Fam Med 2022;20:452–9.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Watson YI,
    2. Arfken CL,
    3. Birge SJ

    . Clock completion: an objective screening test for dementia. J Am Geriatr Soc 1993;41:1235–40.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Mendes-Santos LC,
    2. Mograbi D,
    3. Spenciere B,
    4. Charchat-Fichman H

    . Specific algorithm method of scoring the clock drawing test applied in cognitively normal elderly. Dement Neuropsychol 2015;9:128–35.

    OpenUrlPubMed
13. 13.↵
    1. Coronado GD,
    2. Sanchez J,
    3. Petrik A,
    4. Kapka T,
    5. DeVoe J,
    6. Green B

    . Advantages of wordless instructions on how to complete a fecal immunochemical test: lessons from patient advisory council members of a federally qualified health center. J Cancer Educ 2014;29:86–90.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Greegor DH

    . Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA 1967;201:943–5.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Songster CL,
    2. Barrows GH,
    3. Jarrett DD

    . Immunochemical detection of fecal occult blood–the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer. Cancer. 1980;45:1099–102.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Simon JB

    . Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology 1985;88:820–37.

    OpenUrlPubMedWeb of Science
17. 17.↵
    1. Barrows GH,
    2. Burton RM,
    3. Jarrett DD,
    4. Russell GG,
    5. Alford MD,
    6. Songster CL

    . Immunochemical detection of human blood in feces. Am J Clin Pathol 1978;69:342–6.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Irons GV Jr.,
    2. Kirsner JB

    . Routine chemical tests of the stool for occult blood: an evaluation. Am J Med Sci 1965;249:247–60.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Allison JE

    . The role of fecal occult blood testing in screening for colorectal cancer. Pract Gastroenterol 2007;0:20–32.

    OpenUrl
20. 20.↵
    1. Grobbee EJ,
    2. Wisse PH,
    3. Schreuders EH,
    4. et al

    . Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals. Cochrane Database Syst Rev 2022;6:Cd009276.

    OpenUrlPubMed
21. 21.↵
    1. Deutekom M,
    2. van Rossum LG,
    3. van Rijn AF,
    4. et al

    . Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective. Scand J Gastroenterol 2010;45:1345–9.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Coury J,
    2. Ramsey K,
    3. Gunn R,
    4. Judkins J,
    5. Davis M

    . Source matters: a survey of cost variation for fecal immunochemical tests in primary care. BMC Health Serv Res 2022;22:204.

    OpenUrlPubMed
23. 23.↵
    1. Daly JM,
    2. Bay CP,
    3. Xu Y,
    4. Levy BT

    . Effect of ambient temperature variations on positivity of manual fecal immunochemical tests. J Prim Care Community Health 2015;6:243–9.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Shin HY,
    2. Suh M,
    3. Choi KS,
    4. et al

    . Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study. BMC Cancer 2018;18:365.

    OpenUrlPubMed
25. 25.↵
    1. de Klerk CM,
    2. Wieten E,
    3. van der Steen A,
    4. et al

    . Participation and ease of use in colorectal cancer screening: a comparison of 2 fecal immunochemical tests. Am J Gastroenterol 2019;114:511–8.

    OpenUrlPubMed